Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation

被引:4
|
作者
Kuroi, Taiga [1 ]
Fujii, Nobuharu [1 ,2 ]
Ichimura, Koichi [3 ]
Seike, Keisuke [1 ,2 ]
Yamamoto, Akira [1 ]
Kambara, Yui [1 ]
Sugimoto, Seiichiro [4 ]
Otani, Shinji [4 ]
Saeki, Kyosuke [1 ]
Fujiwara, Hideaki [1 ]
Nishiomori, Hisakazu [1 ]
Oto, Takahiro [4 ]
Maeda, Yoshinobu [1 ,5 ]
机构
[1] Okayama Univ Hosp, Dept Hematol & Oncol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan
[2] Okayama Univ Hosp, Div Transfus, Okayama, Japan
[3] Hiroshima City Hiroshima Citizens Hosp, Dept Pathol, Hiroshima, Japan
[4] Okayama Univ Hosp, Dept Organ, Transplant Ctr, Okayama, Japan
[5] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
关键词
Bronchiolitis obliterans syndrome; Macrophage; Allogeneic hematopoietic cell transplantation; Graft-versus-host disease; Lung transplantation; VERSUS-HOST-DISEASE; ORGANIZING PNEUMONIA; LUNG;
D O I
10.1007/s12185-021-03214-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Bronchiolitis obliterans syndrome (BOS) remains one of the most devastating manifestations of chronic graft-versus-host disease in hematopoietic cell transplantation (HCT). Recent findings of BOS after lung transplantation indicate that donor (lung)-derived lung-resident macrophages contribute to BOS, suggesting that differences in the origin of immune cells and localized antigen-presenting cells cause the onset of BOS. Methods We identified the phenotype and origin of infiltrating macrophages using immunohistochemistry and fluorescence in situ hybridization in eight sex-mismatched HCT recipients who underwent lung transplantation for BOS after HCT. Results Most of the infiltrating macrophages appeared to be derived from donor (hematopoietic) cells in patients who developed BOS following HCT. Macrophages observed in the early-stage region of BOS were positive for cluster of differentiation (CD)68 and inducible nitric oxide synthase (iNOS) and negative for CD163 and CD206, suggesting an M1 phenotype. In the late-stage region, macrophages were negative for CD68 and iNOS in all patients, but also positive for CD163 and CD206 in some patients. Conclusions Donor-derived M1-macrophages may be involved in the pathogenesis of the early-stage region of BOS. In addition, some macrophages in the late-stage region showed M2 polarization that might be involved in fibrosis.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [1] Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation
    Taiga Kuroi
    Nobuharu Fujii
    Koichi Ichimura
    Keisuke Seike
    Akira Yamamoto
    Yui Kambara
    Seiichiro Sugimoto
    Shinji Otani
    Kyosuke Saeki
    Hideaki Fujiwara
    Hisakazu Nishiomori
    Takahiro Oto
    Yoshinobu Maeda
    International Journal of Hematology, 2021, 114 : 701 - 708
  • [2] Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Williams, Kirsten M.
    Chien, Jason W.
    Gladwin, Mark T.
    Pavletic, Steven Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (03): : 306 - 314
  • [3] Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
    Kim, Yu Ri
    Haam, Seok Jin
    Park, Yoon Ghil
    Lim, Beom Jin
    Park, Yoo Mi
    Paik, Hyo Chae
    YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 1054 - 1057
  • [4] Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    S Watanabe
    Y Waseda
    H Kimura
    H Takato
    K Ohata
    Y Kondo
    K Kasahara
    S Nakao
    Bone Marrow Transplantation, 2015, 50 : 1250 - 1252
  • [5] Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    Watanabe, S.
    Waseda, Y.
    Kimura, H.
    Takato, H.
    Ohata, K.
    Kondo, Y.
    Kasahara, K.
    Nakao, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 (09) : 1250 - 1252
  • [6] Bronchiolitis Obliterans Syndrome Epidemiology after Allogeneic Hematopoietic Cell Transplantation
    Au, Brandon K. C.
    Au, Margaret A.
    Chien, Jason W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 1072 - 1078
  • [7] Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    Gazourian, Lee
    Coronata, Anna Maria F.
    Rogers, Angela J.
    Weinhouse, Gerald L.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ritz, Jerome
    Ho, Vincent T.
    Baron, Rebecca M.
    Washko, George R.
    RESPIRATORY MEDICINE, 2013, 107 (02) : 276 - 283
  • [8] Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation
    Chien, Jason W.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (01) : 127 - 135
  • [9] Ruxolitinib for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
    Kulagin, Egor A.
    Volkova, Alisa G.
    Dotsenko, Anna A.
    Yanbukhtina, Valeria R.
    Rabik, Julia D.
    Smirnova, Anna G.
    Golubovskaya, Irina K.
    Trofimov, Vasiliy I.
    Moiseev, Ivan S.
    BLOOD, 2021, 138
  • [10] Nintedanib in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
    Tang, Wenjiao
    Yu, Ting
    Dong, Tian
    Liu, Ting
    Ji, Jie
    CHEST, 2020, 158 (03) : E89 - E91